{"id":"W2158902152","doi":"10.1161/atvbaha.107.139402","title":"Oral, Direct Factor Xa Inhibitors in Development for the Prevention and Treatment of Thromboembolic Diseases","year":2007,"lang":"en","type":"review","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Rivaroxaban; Apixaban; Medicine; Intensive care medicine; Oral anticoagulant; Anticoagulant; Coagulation; Coagulation cascade; Warfarin; Surgery; Atrial fibrillation; Internal medicine; Thrombin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002062369,0.0003354606,0.001818288,0.000208807,0.0001019221,0.00001981188,0.00005486539,0.0002101651,0.00002031981],"category_scores_gemma":[0.00003211758,0.0001902361,0.0005121009,0.0001698439,0.0001319446,0.0000383258,0.00005801617,0.00004444413,0.00000169234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007453449,"about_ca_system_score_gemma":0.0000680241,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003228168,"about_ca_topic_score_gemma":0.00005722151,"domain_scores_codex":[0.9985282,0.0001132332,0.0006519848,0.0003884915,0.00008696238,0.0002311176],"domain_scores_gemma":[0.9990728,0.0003389068,0.0002536423,0.0002381035,0.00002920229,0.00006732133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000006204576,0.00009727178,0.06223768,0.002307194,0.001693115,2.206581e-8,0.0002281884,8.046425e-8,0.00007573011,0.0000847127,0.00002456995,0.9332452],"study_design_scores_gemma":[0.0008109154,0.0003787236,0.4346589,0.001139659,0.00142169,1.033865e-7,0.00002925928,0.000001898459,0.000007936447,0.000005096077,0.561405,0.0001408502],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.05698176,0.9392027,0.00008333912,0.00008880467,0.0002523318,0.003296549,0.00004870611,0.00002584522,0.0000200119],"genre_scores_gemma":[0.01874761,0.9805339,0.0002309807,0.00001866405,0.0001609848,0.0001027248,0.000164914,0.00002788351,0.00001235611],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9331044,"threshold_uncertainty_score":0.7757604,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2298781414759978,"score_gpt":0.4200790731717425,"score_spread":0.1902009316957447,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}